Terug
Dagbereik
€ 4,88
€ 5,31
52-Weeksbereik
€ 2,25
€ 8,90
Volume
2.173.523
50D / 200D Gem.
€ 6,89
/
€ 5,61
Vorige Slotkoers
€ 5,34
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,7 | 0,3 |
| P/B | — | 2,9 |
| ROE % | -565,3 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 18,00
+244.8%
Low: € 15,00
High: € 22,00
Forward WPA
-€ 1,79
Omzet Sch.
560000
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 0,81
€ 0,81 – € 0,81
|
540 M | 2 |
| FY2028 |
-€ 0,83
-€ 0,83 – -€ 0,83
|
250 M | 3 |
| FY2027 |
-€ 1,63
-€ 1,63 – -€ 1,63
|
43 M | 2 |
Insider Trading Activity
14 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 11, 2026 |
Nath Kabir
Chief Executive Officer
|
other | 13.131 | € 6,89 | € 90.473 |
| Mar 11, 2026 |
Loxam Teri
Chief Financial Officer
|
other | 1.781 | € 6,89 | € 12.271 |
| Mar 2, 2026 |
Loxam Teri
Chief Financial Officer
|
other | 4.467 | € 7,02 | € 31.358 |
| Feb 2, 2026 |
Nath Kabir
Chief Executive Officer
|
other | 16.181 | € 6,61 | € 106.956 |
| Oct 29, 2025 |
JONAS JEFFREY M
Director
|
grant | 52.000 | — | — |
| Aug 1, 2025 |
Nath Kabir
Chief Executive Officer
|
other | 6.366 | € 4,34 | € 27.628 |
| Jul 29, 2025 |
Gover Justin D.
Director
|
grant | 52.000 | — | — |
| Jun 12, 2025 |
McQuade Robert
Director
|
grant | 26.000 | — | — |
| Jun 12, 2025 |
SANTINI GINO
Director
|
grant | 39.000 | — | — |
| Jun 12, 2025 |
Jenkins Annalisa
Director
|
grant | 26.000 | — | — |
| Jun 12, 2025 |
Karydas Daphne
Director
|
grant | 26.000 | — | — |
| Jun 12, 2025 |
Norton David Y
Director
|
grant | 26.000 | — | — |
| Jun 12, 2025 |
Lonngren Thomas
Director
|
grant | 26.000 | — | — |
| Jun 12, 2025 |
McGoldrick Linda
Director
|
grant | 26.000 | — | — |
Belangrijkste Punten
Negative free cash flow of -157,24M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-565,28%
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,77
Interest Coverage39,64
Waardering
P/E Ratio
-1,74
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -287,86M |
| ROE | -565,28% | ROA | -136,85% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -157,24M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,77 |
| Interest Coverage | 39,64 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -1,74 | P/B Ratio | N/A |
| P/S Ratio | N/A | PEG Ratio | -0,07 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 501,13M | Enterprise Value | 372,45M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -287,86M | -155,12M | -118,46M | -91,51M | -71,74M |
| EPS (Diluted) | -3,08 | -2,30 | -2,32 | -2,16 | -1,79 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -179,04M | -178,21M | -136,92M | -110,40M | -83,22M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 210,35M | 213,67M | 275,99M | 197,29M | 300,90M |
| Total Liabilities | 263,20M | 58,97M | 50,24M | 16,01M | 16,49M |
| Shareholders' Equity | -52,85M | 154,70M | 225,74M | 181,28M | 284,41M |
| Total Debt | 20,93M | 32,19M | 33,05M | 1,93M | 3,61M |
| Cash & Equivalents | 149,61M | 165,08M | 220,20M | 143,21M | 273,24M |
| Current Assets | 191,49M | 201,29M | 261,30M | 191,65M | 295,30M |
| Current Liabilities | 247,80M | 34,02M | 19,60M | 15,60M | 15,11M |